Nirula Ajay 4

What Happened
Ajay Nirula, a director of Zura Bio Ltd. (ZURA), received an option-style equity award for 51,000 shares on June 17, 2026. The filing records the grant as a derivative award at $0.00 per share (transaction code A). This is an equity grant (not a sale or open-market purchase) and does not represent an immediate cash transaction or sale of shares.

Key Details

• Transaction date: 2026-06-17; Form 4 filed: 2026-06-22.
• Transaction type/code: Award/Grant (derivative) — 51,000 shares; price shown $0.00.
• Vesting: The option vests in 12 substantially equal monthly installments over one year beginning June 17, 2026. Any remaining unvested portion will vest the day before the next annual shareholders’ meeting, subject to continued service (see footnote F1).
• Shares owned after transaction: Not specified in the summary provided — consult the full Form 4 for total holdings.
• Timeliness: The Form 4 was filed five days after the transaction date; Form 4s are typically due within two business days, so check the filing for any timeliness designation or explanation.

Context
This was an equity award (option grant), not an exercise or sale. Such grants are common as part of director compensation and do not by themselves indicate buying or selling sentiment. For the exact vesting schedule, potential exercise price, and total post-transaction ownership, refer to the submitted Form 4 (Accession 0002116832-26-000007).